CHYM — Stock Film
STOCK FILMSCENE 1/11CHYM · $31.95
Stock Expert AI presents
CHYM
Chime Financial, Inc. Class A Common Stock
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Chime Financial, Inc. Class A Common Stock. A quick introduction.

On the stock market since 2025, it operates in the world of money and finance. It has 1,519 employees. Now — the numbers.

on the stock market since 2025
1,519 employees
$12B market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.5.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are growing, year after year.

Average growth of 29% a year over the last 3 years. Red columns mark years that ended in a loss.

$1B
2022
$1.3B
2023
$1.7B
2024
$2.2B
2025
In the vault right now:
$0
DEBT: $134.7M
At this pace, that money lasts about 1 year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
71
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
77
strong

For a bank, strength is measured by capital buffers and reserves — not cash minus debt.

VALUATION
41
weak

Clearly below the class average.

GROWTH
43
weak

Clearly below the class average.

PRICE MOMENTUM
92
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Heavy investment in the future10/10
Few are betting against it10/10
THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 3 years, sales grew about 29% a year on average.

2
THE BRIGHT SIDE · 2/2
Sales are holding up

The company sells $2.2B a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/3
The losses continue

A loss of $1.0B against $2.2B in annual sales.

2
THE RISKS · 2/3
The cash has a countdown

At the current pace of spending, the cash lasts about 1 year. After that, the company needs to find new money.

3
THE RISKS · 3/3
Executives lean toward selling

Over the last 12 months, executives reported 141 sells against just 45 buys. Not an alarm bell by itself, but a number worth watching.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, CHYM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: CHYM has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film